EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cationic Metal‐Organic Layer Delivers siRNAs to Overcome Radioresistance and Potentiate Cancer Radiotherapy

Xin Ma, Xiaomin Jiang, Zitong Wang, Yingjie Fan, Jinhong Li, Cathleen Chow, Chaoyu Wang, Chenghua Deng, Wenbin Lin iD

Angewandte Chemie International Edition · 2025

DOI: 10.1002/anie.202419409 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2025. Verfasst von Xin Ma und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, The University of Chicago, Chicago, IL 60637, USA. Hauptthemen laut MEDLINE: RNA, Small Interfering, Metal-Organic Frameworks, Colorectal Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radiotherapy plays an important role in modern oncology, but its treatment efficacy is limited by the radioresistance of tumor cells. As a member of the inhibitor of apoptosis protein family, survivin plays a key role in developing radioresistance by mediating apoptosis evasion, promoting epithelial‐mesenchymal transition, and modulating cell cycle dynamics. Efficient downregulation of survivin expression presents a promising strategy to enhance the antitumor effects of radiotherapy. Herein, we report the design of a hafnium‐porphyrin‐based cationic metal‐organic layer (CMOL) with quaternary ammonium capping groups to deliver small interfering RNAs (siRNAs) for enhanced radiotherapy. The CMOL@siRNA nanoplatform not only increased energy deposition from X‐rays and reactive oxygen species generation via a unique radiotherapy‐radiodynamic therapy process, but also effectively delivered siRNAs to downregulate survivin expression and ameliorate radioresistance of cancer cells. Consequently, CMOL@siRNA in combination with low‐dose X‐ray irradiation demonstrated remarkable antitumor efficacy with 96.9 % and 91.4 % tumor growth inhibition in murine colorectal carcinoma and triple‐negative breast cancer models, respectively.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Small InterferingMetal-Organic FrameworksColorectal NeoplasmsAnimalsMiceHumansCationsCell Line, TumorSurvivinRadiation ToleranceFemaleTriple Negative Breast NeoplasmsApoptosis

Stichwörter der Autor:innen

Metal-organic layersRadioresistanceRadiosensitizersradiotherapysiRNA Delivery

Substanzen

RNA, Small InterferingMetal-Organic FrameworksCationsSurvivin

Autor:innen und Institutionen

  • Department of Chemistry, The University of Chicago, Chicago, IL 60637, USA.
  • Department of Radiation and Cellular Oncology, Ludwig Center for Metastasis Research, The University of Chicago, Chicago, IL 60637, USA.

ORCID-Profile: Wenbin Lin

Förderung

  • NCI NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Ma, X., Jiang, X., Wang, Z., Fan, Y., Li, J., Chow, C., Wang, C., Deng, C., & Lin, W. (2025). Cationic Metal‐Organic Layer Delivers siRNAs to Overcome Radioresistance and Potentiate Cancer Radiotherapy. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202419409

Vancouver

Ma X, Jiang X, Wang Z, Fan Y, Li J, Chow C, et al. Cationic Metal‐Organic Layer Delivers siRNAs to Overcome Radioresistance and Potentiate Cancer Radiotherapy. Angewandte Chemie International Edition. 2025. doi:10.1002/anie.202419409

BibTeX
@article{Ma2025,
  author = {Ma, Xin and Jiang, Xiaomin and Wang, Zitong and Fan, Yingjie and Li, Jinhong and Chow, Cathleen and Wang, Chaoyu and Deng, Chenghua and Lin, Wenbin},
  title = {Cationic Metal‐Organic Layer Delivers siRNAs to Overcome Radioresistance and Potentiate Cancer Radiotherapy},
  journal = {Angewandte Chemie International Edition},
  year = {2025},
  doi = {10.1002/anie.202419409}
}
Kostenlos starten →